- AdventHealth Research Institute
A new systematic review of clinical trials has found that no single dietary pattern consistently improves blood sugar control or weight management in youth and adults living with type 1 diabetes. The findings highlight the urgent need for more rigorous research into precision nutrition strategies tailored to individual patient needs.
Researchers analyzed 12 studies comprised of 11 clinical trials conducted between 2011 and 2024, involving 668 youth and adults with type 1 diabetes. The studies compared various diet patterns including Mediterranean, low and moderate carbohydrate, low fat, and generally healthful diets. Outcomes that were pooled in meta-analyses included glycated hemoglobin (HbA1c) and weight. Results showed:
No consistent benefit of any specific diet pattern in randomized trials.
Low-carbohydrate diets in single-arm studies suggested improvements in HbA1c (−0.63% [95% CI, −0.99 to −0.27]), but evidence quality was graded as being very low.
Meta-analyzed results suggested the possibility of variation in response to diet patterns between individuals, based upon wide pooled confidence intervals.
However, dedicated studies are needed to evaluate whether true heterogeneity in response to diet patterns exists, which would indicate the need to tailor diets to individual characteristics in “precision nutrition” paradigms.
Despite these findings, most studies did not stratify results by participant characteristics such as age, sex, or baseline metabolic profile — limiting insights into who might benefit most from specific dietary approaches.
The study underscores the importance of determining whether diet approaches that account for interindividual differences in metabolism, lifestyle, and treatment goals are more effective than one-size-fits-all dietary recommendations.
Conclusion
High-quality randomized trials are needed to determine whether tailored nutrition recommendations will help to optimize glycemia and weight management in people with type 1 diabetes. Until strategies for determining the optimal diet for a given individual emerge, current recommendations to individualize diet counseling to individual and cultural preferences should continue to be followed.
Recent News
New Study Points to Promising Way to Protect Kidneys in Type 1 Diabetes
Richard E. Pratley, M.D., senior investigator and diabetes program lead at the AdventHealth Translational Research Institute (TRI), served as one of the lead researchers on the international FINE-ONE...
Understanding Hypoglycemia and the CLEAR Study
The CLEAR Study is a groundbreaking, international research effort funded by the NIH that aims to help people with Type 1 diabetes (T1D) who can no longer sense when their blood sugar is dangerously...
Recognizing the Unrecognized: Advancing Research in Childhood Sjögren’s Disease
Sjögren’s disease has been recognized in adults for almost a century, first described by Swedish ophthalmologist Henrik Sjögren in the early 20th century. One of the biggest challenges in recognizing...
Did you know? Women, Hormones, and Heart Risk
Heart disease is often thought of as a “man’s disease,” but it remains the leading cause of death for women in the United States. We asked Katie Love, MD, MSc, an investigator at the AdventHealth...
Weight-Loss Drugs, Hormones, and Midlife: What Women Need to Know
Understanding the connection between GLP-1 medications and hormone therapy
Women, Brain Health, and the Alzheimer’s Puzzle
Why scientists are taking a closer look at why women face higher Alzheimer’s risk
How Diet Shapes Gut Microbes and Energy Absorption
What we eat has a big impact on the bacteria living in our gut, which in turn affects how our bodies use energy—something that plays a major role in the development and treatment of obesity.
AdventHealth Neuroscience Institute Launches NIH-Funded THRIVE Trial
AdventHealth Neuroscience Institute has launched THRIVE, an NIH-funded clinical trial led by Lauren Oberlin, PhD, geriatric neuropsychologist and neuroscience researcher.
AdventHealth Tampa Enrolls First Patient in the Tectonic CAD IVL Trial
On September 19, 2025, AdventHealth Tampa successfully enrolled its first patient in the Tectonic CAD Intravascular Lithotripsy (IVL) Trial, led by Dr. Mahmaljy and his team.
MANIFEST US Study Presented as a Late-Breaking Clinical Trial at AHA
The cardiovascular team is excited to highlight the MANIFEST US study, which was presented on November 10th as a Late-Breaking Clinical Trial at the American Heart Association (AHA) Scientific...
Nourishing Your Gut: Dr. Karen Corbin on the Power of Fiber
Dr. Karen Corbin, associate investigator at the AdventHealth Translational Research Institute for Metabolism and Diabetes in Orlando, emphasizes the essential role of diet in maintaining a healthy gut...
Southeast Region – Redmond Campus: AdventHealth Recognized as Top Enroller Nationally for the CARVTOP-ICD Trial
AdventHealth Research Institute (AHRI) is proud to announce that the Southeast Region’s Redmond Campus has been recognized as the top enrolling site nationally for the CARVTOP-ICD trial.